Corient Private Wealth LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1948780 MIAMI, FL

Position in VIR

as of Jun 30, 2026 · filed Aug 27, 2026 Compact

Position Value

$3,169,110

+$537,666 QoQ

Shares Held

311,002

+5.9% QoQ

Ownership

0.184%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 237 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $248,190,979 across 122 Biotechnology names. VIR ranks #16 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	103,755	$51,538,220
2	IONS	Ionis Pharmaceuticals Inc	196,661	$15,593,250
3	HALO	Halozyme Therapeutics, Inc.	187,166	$14,649,482
4	KRYS	Krystal Biotech, Inc.	30,558	$11,357,491
5	TECH	BIO-TECHNE Corp	119,590	$8,449,033
6	REGN	Regeneron Pharmaceuticals, Inc.	12,473	$7,777,414
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,969	$7,215,387
8	CLDX	Celldex Therapeutics, Inc.	176,956	$6,584,532

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,169,110	311,002	+5.9%	Shares	Sole	2026-08-27
2026-03-31	$2,631,444	293,688	+12.7%	Shares	Sole	2026-05-15
2025-12-31	$1,572,033	260,702	+0.4%	Shares	Sole	2026-03-09
2025-09-30	$1,482,864	259,696	+0.1%	Shares	Sole	2025-11-14
2025-06-30	$1,307,083	259,342	+0.4%	Shares	Sole	2025-09-26
2025-03-31	$1,674,276	258,376	+0.3%	Shares	Sole	2025-05-14
2024-12-31	$1,890,196	257,520	-9.0%	Shares	Sole	2025-02-10
2024-09-30	$2,120,156	283,065	+6.4%	Shares	Sole	2024-11-12
2024-06-30	$2,368,263	266,097	-1.4%	Shares	Sole	2024-08-13
2024-03-31	$2,734,208	269,912	+1.0%	Shares	Sole	2024-05-09
2023-12-31	$2,688,826	267,279	+11.3%	Shares	Sole	2024-02-09
2023-09-30	$2,250,336	240,164	-0.3%	Shares	Sole	2023-11-03
2023-06-30	$5,911,779	241,002	+0.1%	Shares	Sole	2023-08-10
2023-03-31	$5,604,230	240,835	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.